Recommended Talks:

2nd Env Manufacturing Workshop
Choosing the right protein
September 2016
Hans Langedijk, Janssen, J&J
2nd Env Manufacturing Workshop
Case study of formulating protein for P5
September 2016
Antu Dey, International AIDS Vaccine Initiative (IAVI)
Product Development Boot Camp
Preclinical data and regulatory considerations
November 2015
Jim Ackland, Global Biosolutions
Design, Test, Repeat: Paths to Elicit Neutralizing Antibodies - A virtual Mini Symposium
May 2015
Introduction
Bargavi Thyagarajan, Global HIV Vaccine Enterprise
Chair
Robin Shattock, Imperial College London
HIV-1 antibody lineages: Implications for vaccine design
John Mascola, Vaccine Research Center, NIAID, NIH
Sequential Env Immunisations as a Path to an HIV Vaccine
Larry Liao, Duke Human Vaccine Institute, Duke University School of Medicine
Native Flexibly Linked Well-ordered Trimers
Richard Wyatt, IAVI Neutralizing Antibody Center, The Scripps Research Institute
Diversity of HIV-1 Env Vaccine-Induced Antibody Responses
Gunilla Hedestam, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet
Moderator
Penny Moore, National Institute for Communicable Diseases South Africa
Robin Shattock, Imperial College London
Panelist
John Mascola, Vaccine Research Center, NIAID, NIH
Larry Liao, Duke Human Vaccine Institute, Duke University School of Medicine
Gunilla Hedestam, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet
Richard Wyatt, IAVI Neutralizing Antibody Center, The Scripps Research Institute
2nd Workshop on Prevention Trials in Infants Born to HIV-Positive Mothers
bNAbs development in infants
February 2017
Philip Goulder, Oxford University

Search:

Search term(s):

Search for text in:

separate each search
term with a space

Multiple terms:

Conference Years:

Content Type:

Latest Additions

Meeting Format: 1.5 day meeting   |   July 2017
The third annual workshop brought together experts to discuss advances in manufacturing of recombinant HIV Env protein, with special focus on the challenges production for early stage clinical trials. Webcasts | Learn More
Meeting Format: Video Recordings   |   July 2017
The IAS 2017 satellite, "Future Perfect," explored the latest in HIV vaccine design, development, and testing, with a focus on current trials on an efficacy pathway and promising approaches in pre- or early clinical trials. Webcasts | Learn More
Meeting Format: 2 day meeting   |   May 2017
The workshop brought together imaging experts from inside and outside the HIV/SIV field to discuss the strengths, limitations and applications of emerging imaging technologies in HIV/SIV research. Webcasts | Learn More
Meeting Format: Video Recordings   |   March 2017
The ePanel and SciTalks addressed a broad range of topics pertinent to state-of-the-art HIV vaccine research. Webcasts | Learn More
Meeting Format: 1.5 day meeting   |   February 2017
This meeting convened key experts to discuss the conduct of efficacy trials of potential new immune-based approaches to interrupt MTCT of HIV. Webcasts | Learn More
Meeting Format: Video Recordings   |   November 2016
The ePanel and SciTalks addressed a broad range of topics pertinent to state-of-the-art HIV vaccine research. Webcasts | Learn More
Meeting Format: 4 hour meeting   |   October 2016
An interactive session at HIVR4P 2016 to discuss HIV research capacity strengthening in Africa and to launch AAVVi.net. Scientists, advocates and policy makers share success stories, identify gaps, challenges and opportunities. Webcasts
Meeting Format: 1 day meeting   |   September 2016
The meeting reviewed the state of the field and latest advances in Env production, purification, and formulation. Webcasts | Learn More
Meeting Format: 1 day meeting   |   July 2016
Review the neut-sensitivity of Tiered virus panels and discuss the appropriate use of Tier-1A, -1B and -2 viruses for future vaccine development efforts. Webcasts | Learn More
Meeting Format: 1 day meeting   |   June 2016
Investigators generating and characterizing new SHIVs and clinical researchers using such challenge viruses convened to advance current research efforts. Webcasts
1 2 3